Donate For Public and Patients Store Search

U007 - Warts

Friday, March 1; 7:30 AM - 8:30 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Outline the types of warts and their biologic features.
  • Categorize therapeutic options for wart therapy.
  • Develop a basic treatment plan for common, genital and cryotherapy resistant warts.


Warts are an ancient and persistent medical problem caused by infection with Human Papillomavirus (HPV) and affecting different populations at different ages in different locations. There are many structural features to HPV that confer virulence and differences in biologic behavior. This session reviews the biology of HPV, modes of transmission and especially therapeutic options. Choice of therapeutics reviewed will include common therapeutics such as cryotherapy and a variety of alternative agents for therapy of cryotherapy resistant warts including immunotherapy and new agents on the market that make use of novel therapeutic strategies. The pipeline in HPV therapy will be addressed.


  • Silverberg, Nanette Blythe, MD: Pfizer Inc. – Speaker/Faculty Education(H); Regeneron – A(H); regeneron – SP(H); Valeant Pharmaceuticals International – A(H);
Friday, March 1
7:30 AM
Dr. Silverberg / Warts
Event Details
  • Date
    Friday, March 1
  • Time
    7:30 AM - 8:30 AM
  • Location
    Room 146A
  • CME Credits
  • Type
  • Nanette Blythe Silverberg, MD, FAAD